National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published

March 19, 2025

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 90 Issue 52 (Wednesday, March 19, 2025)</title>
</head>
<body><pre>
[Federal Register Volume 90, Number 52 (Wednesday, March 19, 2025)]
[Notices]
[Page 12751]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2025-04570]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR Phase II Clinical Trial 
Implementation (U44 Clinical Trial Required).
    Date: April 2, 2025.
    Time: 9:00 a.m. to 10:00 a.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3D54, 
Rockville, MD 20892.
    Meeting Format: Video Assisted Meeting.
    Contact Person: Tara Capece, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institute of Allergy and Infectious Diseases, National 
Institutes of Health, 5601 Fishers Lane, Room 3D54, Rockville, MD 
20892, 240-191-4281, <a href="/cdn-cgi/l/email-protection#741715041117110046341a1d151d105a1a1d1c5a131b02"><span class="__cf_email__" data-cfemail="b5d6d4c5d0d6d0c187f5dbdcd4dcd19bdbdcdd9bd2dac3">[email&#160;protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning 
Grants (R34 Clinical Trial Not Allowed) and Investigator Initiated 
Extended Clinical Trial (R01 Clinical Trial Required).
    Date: April 2, 2025.
    Time: 10:00 a.m. to 11:30 a.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3D54, 
Rockville, MD 20892.
    Meeting Format: Video Assisted Meeting.
    Contact Person: Tara Capece, Ph.D., Scientific Review Officer, 
Scientific Review Program, National Institute of Allergy and 
Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 3D54, Rockville, MD 20892, 240-191-4281, 
<a href="/cdn-cgi/l/email-protection#c2a1a3b2a7a1a7b6f082acaba3aba6ecacabaaeca5adb4"><span class="__cf_email__" data-cfemail="036062736660667731436d6a626a672d6d6a6b2d646c75">[email&#160;protected]</span></a>.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning 
Grants (R34 Clinical Trial Not Allowed).
    Date: April 10, 2025.
    Time: 2:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3D54 
Rockville, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Tara Capece, Ph.D., Scientific Review Officer, 
Scientific Review Program, Division of Extramural Activities, 
National Institutes of Health, NIAID, National Institute of Allergy 
and Infectious Diseases, National Institutes of Health, 5601 Fishers 
Lane, Room 3D54, Rockville, MD 20892, 240-191-4281, 
<a href="/cdn-cgi/l/email-protection#4e2d2f3e2b2d2b3a7c0e20272f272a6020272660292138"><span class="__cf_email__" data-cfemail="a5c6c4d5c0c6c0d197e5cbccc4ccc18bcbcccd8bc2cad3">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 13, 2025.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2025-04570 Filed 3-18-25; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>

View on FederalRegister.gov →Plain-text source

Indexed from Federal Register on March 19, 2025.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.